Literature DB >> 6312746

Intravenous injections of nicotine induce very rapid and discrete reductions of hypothalamic catecholamine levels associated with increases of ACTH, vasopressin and prolactin secretion.

K Andersson, R Siegel, K Fuxe, P Eneroth.   

Abstract

The present findings show that nicotine given i.v. can within minutes induce increases of ACTH, vasopressin and prolactin secretion in the male rat, giving further evidence for the existence of nicotine-like cholinergic receptors involved in the regulation of these hormones. These changes were associated with rapid reductions of NA levels in the subependymal layer of the median eminence, in the nuc, dorsomedialis hypothalami and in the anterior and posterior periventricular hypothalamic area as revealed by quantitative microfluorimetrical measurements of CA fluorescence. Intraindividual correlations indicate the involvement of an inhibitory noradrenergic mechanism in the subependymal layer of the median eminence in the regulation of ACTH secretion, the involvement of noradrenergic mechanisms in the posterior periventricular area in the regulation of prolactin secretion and the involvement of dopaminergic mechanisms in the medial palisade zone of the median eminence in the regulation of prolactin secretion. A rapid rise of prolactin secretion seems to be associated mainly with a reduction of NA levels in the posterior periventricular area indicating the existence of a possible facilitatory noradrenergic mechanism in this region regulating prolactin secretion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312746     DOI: 10.1111/j.1748-1716.1983.tb07237.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  13 in total

Review 1.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

Review 2.  Regulation of feeding-associated peptides and receptors by nicotine.

Authors:  M D Li; S L Parker; J K Kane
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

3.  Effects of withdrawal from chronic exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on the secretion of pituitary hormones in the male rat.

Authors:  K Andersson; K Fuxe; P Eneroth; A Jansson; A Härfstrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

Review 4.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

5.  Developmental exposure to vasopressin increases aggression in adult prairie voles.

Authors:  J M Stribley; C S Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 6.  Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics.

Authors:  L G Miller
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

7.  Nicotinic activation of CRH neurons in extrahypothalamic regions of the rat brain.

Authors:  S G Matta; J D Valentine; B M Sharp
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

8.  Paraventricular nucleus neuronal responses following electrical stimulation of the midbrain dorsal raphe: evidence for cotransmission.

Authors:  D Saphier; S Feldman
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

9.  Effect of nicotine on mRNA levels encoding opioid peptides, vasopressin and alpha 3 nicotinic receptor subunit in the rat.

Authors:  V Höllt; G Horn
Journal:  Clin Investig       Date:  1992 Mar-Apr

10.  Effects of acute continuous exposure of the rat to cigarette smoke on amine levels and utilization in discrete hypothalamic catecholamine nerve terminal systems and on neuroendocrine function.

Authors:  K Andersson; K Fuxe; P Eneroth; L F Agnati; A Härfstrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.